AACR Journals to Publish Impactful Articles Concurrent with Presentation at AACR Annual Meeting 2023

ORLANDO, Fla. – More than 30 articles of advances in cancer research will be presented at the AACR Annual Meeting 2023, April 14-19, and simultaneously published in AACR journals. The list of article titles is available on the AACR journals website. Links to the full text of simultaneously published articles will go live throughout the meeting, as the embargoes lift.

Highlights of the concurrent publications are below. Contact Kathleen Venango at [email protected] to request embargoed copies of these articles.

To be published in Cancer Discovery

Li Fraumeni Syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death
Embargoed until Monday, April 17, noon ET

• Meeting presentation: Monday, April 17, at 2:30 p.m. ET, Late-breaking Research Minisymposium; Meeting abstract
• Presenting author: Joshua Choe, BA
• Corresponding author: Carol Prives, PhD, a professor of biology at Columbia University

Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC
Embargoed until Monday, April 17, 2:30 p.m. ET

• Meeting presentation: Monday, April 17, at 2:30 p.m. ET, Biomarkers of Response in Novel Molecular Therapeutics Minisymposium; Meeting abstract
• Presenting and corresponding author: Ferdinandos Skoulidis, MD, PhD, an associate professor of thoracic/head and neck medical oncology at The University of Texas MD Anderson Cancer Center

To be published in Blood cancer discovery

METTL3-mediated m6A modification controls splicing factor abundance and contributes to CLL progression
Embargoed until Monday, April 17, noon ET

• Meeting presentation: Monday, April 17, at 2:30 p.m. ET, Epigenetics Mechanisms in Cancer Minisymposium; Meeting abstract
• Presenting author: Yiming Wu, PhD, a postdoctoral fellow at City of Hope
• Corresponding author: Lili Wang, MD, PhD, an associate professor of systems biology at City of Hope

Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of human acute myeloid leukemia
Embargoed until Monday, April 17, noon ET

• Meeting presentation: Monday, April 17, at 2:30 p.m. ET, Late-breaking Research Minisymposium; Meeting abstract
• Presenting and corresponding author: Eirini Papapetrou, MD, PhD, a professor of oncological sciences and medicine at the Icahn School of Medicine at Mount Sinai

To be published in Clinical cancer research

Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical implications
Embargoed until Sunday, April 16, noon ET

• Meeting presentation: Sunday, April 16, at 3:00 p.m. ET, Advancing Cancer Research Through an International Cancer Registry: AACR Project GENIE Use Cases; Meeting abstract
• Presenting author: Mohamed Gouda, MBBCh, a postdoctoral fellow at The University of Texas MD Anderson Cancer Center
• Corresponding author: Vivek Subbiah, MD, an associate professor of investigational cancer therapeutics at The University of Texas MD Anderson Cancer Center

Members of the media are invited to attend all AACR Annual Meeting sessions and can request complimentary meeting registration for in-person or virtual attendance. Please review the AACR’s media registration requirements and policies. Journalists can request registration by filling out this form. Contact Cyprien Pearson-Du Toit at [email protected] with any registration questions.